Infusional Carfilzomib in Patients With Relapsed or Refractory Multiple Myeloma

NCT01351623 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

44

Enrollment

OTHER

Sponsor class

Conditions

Multiple Myeloma

Interventions

DRUG: Carfilzomib

Sponsor

Memorial Sloan Kettering Cancer Center

Collaborators

[object Object]